Sanara MedTech Inc. SMTI Increase Decrease In Accrued Royalties And Expenses
Increase Decrease In Accrued Royalties And Expenses at other companies
Other financials
Where this comes from
Reported directly by Sanara MedTech Inc. in its filing.
Tagged under the XBRL concept SMTI:IncreaseDecreaseInAccruedRoyaltiesAndExpenses.
The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sanara MedTech Inc.'s increase decrease in accrued royalties and expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sanara MedTech Inc.'s increase decrease in accrued royalties and expenses?
- Sanara MedTech Inc. (SMTI) reported increase decrease in accrued royalties and expenses of -$105.44K in Q1 2026.
- How has Sanara MedTech Inc.'s increase decrease in accrued royalties and expenses changed year-over-year?
- Sanara MedTech Inc.'s increase decrease in accrued royalties and expenses decreased by 256.9% year-over-year, from $67.22K to -$105.44K.
- What does increase decrease in accrued royalties and expenses mean?
- The net change in liabilities recognized for royalty obligations and other operational expenses that have been incurred but not yet paid. This provides visibility into the company's short-term operational commitments and the timing of cash outflows related to intellectual property or service agreements.